Silver Book Fact

Death rates from heart disease and stroke are falling in-part because of new drug treatments. According to the National Heart, Lung and Blood Institute, if death rates were the same as those 30 years ago, 815,000 more Americans would die of heart disease annually and 250,000 more would die of stroke.

PhRMA. 2009 Report: Medicines in development for heart disease and stroke. Washington, D.C.: PhRMA; 2009. http://www.phrma.org/sites/default/files/653/heart_2009

Reference

Title
2009 Report: Medicines in development for heart disease and stroke
Publisher
PhRMA
Publication Date
2009
Authors
PhRMA
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A year-long study of patients with congestive heart failure found that increased use of medicines increased pharmaceutical costs by 60%; however, hospital costs declined by 78%, producing a net savings…  
  • Improvements in QoL from TAVR in SAS patients
    Symptomatic aortic stenosis (SAS) patients who underwent transcatheter aortic valve replacement (TAVR) experienced quality of life (QoL) improvements from 5.3 at baseline (10 point scale with 10=best imaginable health state)…  
  • Adjusted-dose warfarin reduced stroke risk in AFib patients
    Meta-analysis of randomized trials found that adjusted-dose warfarin reduced stroke risk in atrial fibrillation patients by 60%. Antiplatelet agents reduced risk by 20%.  
  • Development and widespread use of left ventricular assist devices could result in a 50% decrease in heart failure-related hospitalizations.  
  • A major objective is to control blood pressure and preempt primary and secondary stroke. Assessing specific antihypertensive therapies will identify specific treatments that will lower blood pressure.